Crinetics Pharmaceuticals (CRNX) EPS (Basic) Growth (3y) (2020 - 2026)
Crinetics Pharmaceuticals (CRNX) EPS (Basic) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 37.73% |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 86.43% |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 45.89% |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.45 Bn | 10.53 Mn | -68.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.76% |
| Dec 31, 2025 | -51.92% |
| Sep 30, 2025 | -55.65% |
| Jun 30, 2025 | 15.18% |
| Mar 31, 2025 | 13.84% |
| Dec 31, 2024 | 40.76% |
| Sep 30, 2024 | -49.17% |
| Jun 30, 2024 | 10.01% |
| Mar 31, 2024 | 9.84% |
| Dec 31, 2023 | -105.12% |
| Sep 30, 2023 | 42.00% |
| Jun 30, 2023 | 39.62% |
| Mar 31, 2023 | 37.03% |
| Dec 31, 2022 | 50.49% |
| Sep 30, 2022 | 36.53% |
| Jun 30, 2022 | 32.95% |
| Mar 31, 2022 | 32.99% |
| Dec 31, 2021 | -40.51% |
| Sep 30, 2021 | 30.93% |
| Jun 30, 2021 | 27.61% |